Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Multicenter, Prospective Study of MET Concordance and Gene Profiling in First-line Non-small Cell Lung Cancer (NSCLC) (Genomet)

NCT07613424 is registered in ClinicalTrials.gov with AstraZeneca as lead sponsor.

NCT NCT07613424
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07613424 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Multicenter, Prospective Study of MET Concordance and Gene Profiling in First-line Non-small Cell Lung Cancer (NSCLC) (Genomet)
Lead sponsor
AstraZeneca
Phase
Not applicable
Overall status
Recruiting
Start date
June 2, 2026
Completion date
March 31, 2027
Enrollment
1,000 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

non-small cell lung cancer